Celebrate Sickle Cell Awareness Month with HHS!

Part 1—Trust, Clinical Trials, and Transformative Therapies: Ethical Pathways in Gene Therapy and Sickle Cell Disease https://events.gcc.teams.microsoft.com/event/7a36d5c4-1edc-4d85-aea0-425cfc865c08@d58addea-5053-4a80-8499-ba4d944910df?utm_medium=email&utm_source=govdelivery Part 1: Trust, Clinical Trials, and Transformative Therapies: Ethical Pathways in Gene Therapy and Sickle Cell Disease Date: September 18, 2025 Time: 1:00 – 2:30 PM ET Led by the HHS Office for Human Research Protections, this session will feature individuals living with SCD (“warriors”), clinical researchers, bioethics experts, and community partners discussing ways to build trust and confidence in gene therapy within historically underserved populations. Part 2—Innovations and Advances in Sickle Cell Disease Treatments and Therapies https://events.gcc.teams.microsoft.com/event/10958517-2dd7-4e03-b1d2-a4cb60211fe0@d58addea-5053-4a80-8499-ba4d944910df?utm_medium=email&utm_source=govdelivery Part 2: Innovations and Advances in Sickle Cell Disease Gene Therapies Date: September 25, 2025 Time: 2:00 – 3:30 PM ET Led by the HHS Office of Minority Health, this session will highlight the CMS Cell and Gene Therapy Access Model, which leverages outcomes-based agreements to reduce costs and expand access for eligible warriors enrolled in participating state Medicaid programs.